ITI-214 may increase heart capacity

robertc · July 25, 2018, 4:37pm

Intracellular Therapies drug cantidate for sz and Parkingtons may increase heart capacity in animal trial.

far_cry0 · July 25, 2018, 4:42pm

Thats for cognitive symptoms right…,???

robertc · July 25, 2018, 4:56pm

They theorize that ITI-214 might help cognition. Parkinsons trial started.

Topic		Replies	Views
Preclinical profile of ITI-214, an inhibitor of phosphodiesterase 1, for enhancement of memory performance in rats News	5	887	June 29, 2016
New Schizophrenia Treatments Address Unmet Clinical Needs News	32	1598	March 15, 2018
Intra-Cellular Therapies Announces Completion of Phase 1 Studies for ITI-214, a Phosphodiesterase Type 1 Inhibitor, and Assumes IND Sponsorship for ITI-214 News	0	558	September 22, 2015
Intra-Cellular Therapies ITI-007 Clinical Trial misses endpoints Medications	23	2291	November 4, 2016
FuegoMono 1212 Medications	18	942	January 15, 2017